Fluocinolone acetonide implant in diabetic macular edema: International experts' panel consensus guidelines and treatment algorithm
L Kodjikian, F Bandello, M De Smet… - European Journal …, 2022 - journals.sagepub.com
Center-involving diabetic macular edema (DME) is a leading cause of vision impairment in
working-age adults. While its management is particularly challenging in a poorly compliant …
working-age adults. While its management is particularly challenging in a poorly compliant …
[HTML][HTML] Real-world efficacy and safety of fluocinolone acetonide implant for diabetic macular edema: a systematic review
To assess real-world outcomes of fluocinolone acetonide (FAc) implant in treating diabetic
macular edema (DME), a systematic literature review was conducted on PubMed in order to …
macular edema (DME), a systematic literature review was conducted on PubMed in order to …
[HTML][HTML] Management of patients with diabetic macular edema switched from dexamethasone intravitreal implant to fluocinolone acetonide intravitreal implant
S Baillif, P Staccini, M Weber, MN Delyfer, Y Le Mer… - Pharmaceutics, 2022 - mdpi.com
To assess anatomical and functional outcomes after switching from dexamethasone implant
(DEXi) to fluocinolone acetonide implant (FAci) in 113 diabetic macular edema eyes, a …
(DEXi) to fluocinolone acetonide implant (FAci) in 113 diabetic macular edema eyes, a …
Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN …
SE Mansour, DF Kiernan, DB Roth… - British Journal of …, 2021 - bjo.bmj.com
Background The 0.2 µg/day fluocinolone acetonide (FAc) implant delivers continuous, low-
dose, intravitreal corticosteroid for the treatment of diabetic macular oedema (DMO). This …
dose, intravitreal corticosteroid for the treatment of diabetic macular oedema (DMO). This …
[HTML][HTML] The association of fluid volatility with subretinal hyperreflective material and ellipsoid zone integrity in neovascular AMD
Purpose: To evaluate the association of fluid volatility with ellipsoid zone (EZ) integrity and
subretinal hyperreflective material (SHRM) volume during anti–vascular endothelial growth …
subretinal hyperreflective material (SHRM) volume during anti–vascular endothelial growth …
Functional and Morphological Responses to Fluocinolone Acetonide 0.19 mg in Noninfectious Uveitic Macular Edema Evaluated as the Area-Under-the-Curve
LJ Kessler, GU Auffarth, R Khoramnia - Journal of Ocular …, 2023 - liebertpub.com
Purpose: This study investigated the impact of baseline clinical and optical coherence
tomography (OCT) factors on the response to a 0.19-mg fluocinolone acetonide (FAc) …
tomography (OCT) factors on the response to a 0.19-mg fluocinolone acetonide (FAc) …
The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema
MV Cicinelli, A Rosenblatt, D Grosso, P Zollet… - Eye, 2021 - nature.com
Abstract Background/Objectives To investigate if the visual and anatomic response to the
first dexamethasone implant (DEX) predicts the 12-month clinical outcome after shifting to …
first dexamethasone implant (DEX) predicts the 12-month clinical outcome after shifting to …
Persistent or recurrent diabetic macular edema after fluocinolone acetonide 0.19 mg implant: risk factors and management
MV Cicinelli, A Rabiolo, P Zollet, L Capone… - American Journal of …, 2020 - Elsevier
Purpose To investigate baseline characteristics of patients undergoing additional
antivascular endothelial growth factor (VEGF) injections for residual or recurrent diabetic …
antivascular endothelial growth factor (VEGF) injections for residual or recurrent diabetic …
Reduction in retinal thickness fluctuations after treatment with fluocinolone acetonide implant for DME: a post-hoc analysis of the USER study
CD Riemann, AM Eaton… - … Surgery, Lasers and …, 2020 - journals.healio.com
BACKGROUND AND OBJECTIVE: Assess fluocinolone acetonide implant (FAc) effects on
diabetic macular edema (DME) retinal thickness fluctuations. PATIENTS AND METHODS: A …
diabetic macular edema (DME) retinal thickness fluctuations. PATIENTS AND METHODS: A …
The 0.19-mg fluocinolone acetonide implant for the treatment of diabetic macular edema: an expert consensus
AM Kolomeyer, DA Eichenbaum… - … Surgery, Lasers and …, 2023 - journals.healio.com
Background and Objective: To better understand the level of agreement among retina
specialists on the role of inflammation in diabetic retinopathy (DR) and diabetic macular …
specialists on the role of inflammation in diabetic retinopathy (DR) and diabetic macular …